Newswise (press release) Ciciriello initiated the review when she noticed that many of her patients were getting misinformation about methotrexate . As a low-dose tablet once a week, methotrexate is an effective first line treatment for rheumatoid arthritis. This drug, however ... and more »
Zacks.com The study evaluated two dosing regimens of fostamatinib, 100 mg twice daily and 100 mg twice daily for four weeks followed by 150 mg once daily in combination with methotrexate versus methotrexate along with placebo. The study revealed mixed results on ... and more »
Healio Women with rheumatoid arthritis who treated with methotrexate had lower rates for induced abortions compared with women with the disease not exposed to the drug...
Healio Patients with moderately active rheumatoid arthritis treated with conventional or reduced doses of etanercept with methotrexate maintained lower disease activity compared with patients treated with methotrexate alone after withdrawal of etanercept ...
dailyRx Biologic medications like Actemra and Humira are typically prescribed when patients did not respond well to methotrexate , one of the most effective and commonly used medications to treat rheumatoid arthritis and similar conditions. While biologics are ...
4-traders (press release) Independent research indicates there is a clear value proposition in the optimization of methotrexate through subcutaneous self-administration for both patients and third-party payers. Therefore, we believe that OTREXUP? could expand physician ...
MedPage Today Few rheumatoid arthritis (RA) patients treated with abatacept -- with concomitant methotrexate or not -- developed immunogenic responses that could interfere with efficacy and safety of the biologic agent, a phase II, international, open-label study found.
Seeking Alpha This is a global randomized Phase III study in relapsed CD30 expressing CTCL patients to evaluate single-agent ADCETRIS versus physicians' choice of methotrexate or bexarotene. The primary endpoint is objective response rate with duration of at least 4 ... and more »